4/A: Inari Medical Director Jonathan Root Amends Form 4 Filing to Include Power of Attorney

Jonathan Root, a director at Inari Medical, amends his Form 4 filing to include a previously granted Power of Attorney.

Summary

• This is an amendment to a Form 4 filing by Jonathan Root, a director at Inari Medical, Inc.
• The amendment, filed on May 31, 2024, updates the original Form 4 filed on April 26, 2024.
• The purpose of the amendment is to include the Power of Attorney granted to the attorney-in-fact.
• The original transaction reported was the acquisition of 4,126 shares of Common Stock on April 24, 2024, at a price of $42.41 per share.
• These shares were granted as restricted stock units that vest in full on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.
• Following the reported transaction, Root beneficially owns 541,149 shares of Common Stock directly and 335 shares indirectly through his spouse.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating standard insider transactions. The sentiment is neutral to slightly positive as it reflects ongoing participation by a director in the company's equity.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and 10% owners) to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It assures stakeholders that the director is invested in the company's success through equity ownership.

Key Dates